Nhận Dạng Quốc Tế & Đặc Tính Hóa Học
Monoisotopic mass
418.991696707
InChI
InChI=1S/C17H11BrFN3O4/c18-10-4-3-9(11(19)6-10)8-21-14(24)12-2-1-5-22(12)17(16(21)26)7-13(23)20-15(17)25/h1-6H,7-8H2,(H,20,23,25)/t17-/m1/s1
InChI Key
InChIKey=QCVNMNYRNIMDKV-QGZVFWFLSA-N
IUPAC Name
(3R)-3'-[(4-bromo-2-fluorophenyl)methyl]-3',4'-dihydro-2'H-spiro[pyrrolidine-3,1'-pyrrolo[1,2-a]pyrazine]-2,2',4',5-tetrone
Traditional IUPAC Name
(3R)-3'-[(4-bromo-2-fluorophenyl)methyl]spiro[pyrrolidine-3,1'-pyrrolo[1,2-a]pyrazine]-2,2',4',5-tetrone
SMILES
FC1=C(CN2C(=O)C3=CC=CN3[C@@]3(CC(=O)NC3=O)C2=O)C=CC(Br)=C1
pKa (strongest acidic)
8.52
pKa (Strongest Basic)
-6.9
Refractivity
90.5 m3·mol-1
Cơ Chế Tác Dụng :
AS-3201 is a structurally novel and stereospecifically potent aldose reductase (AKR1B; EC 1.1.1.21) inhibitor, which contains a succinimide ring that undergoes ring-opening at physiological pH levels.
AS-3201 alleviates diabetic neuropathy, a complication of diabetes, by inhibiting aldose reductase and thereby inhibiting the accumulation of intracellular sorbitol that causes diabetic neuropathy. This drug has a stronger inhibitory effect and is longer acting compared to other drugs in this therapeutic area. AS-3201 showed good penetration into the nerve tissue, resulting in dose-dependent inhibition of intraneural accumulation of sorbitol and fructose in a clinical study.
Chỉ Định :
Investigated for use/treatment in neuropathy (diabetic).